Nkarta NKTX
NASDAQ NKTX
$2.58 +0.02 (+0.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nkarta (NKTX) Price to Sales (2020)

Updated

Nkarta's (NKTX) Price to Sales came in at 509525.54 for Q3 2020.

Analysis

Nkarta (NKTX) Price to Sales (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Nkarta 184.79 Mn 184.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 509,525.54
API Access

Nkarta Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=NKTX&period=max&api_key=YOUR_API_KEY